Print

Purpose

Provide patients with serious AdV infection or disease access to treatment with BCV.

Condition

Eligibility

Eligible Ages
Over 2 Months
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Confirmed serious AdV infection based on clinical symptoms and laboratory testing showing AdV in the blood or other bodily fluids - Able to swallow medication, either tablet or liquid

Exclusion Criteria

  • Previous dosing with Brincidofovir - If female, not pregnant or trying to become pregnant

Study Design

Phase
Study Type
Expanded Access

Recruiting Locations

University of Arkansas Medical Center
Little Rock, Arkansas 72205

Children's Hospital LA
Los Angeles, California 90027

UCLA Medical Center
Los Angeles, California 90095

Children's Hospital of Orange County
Orange, California 92868

Pediatric Stem Cell Transplantation Stanford University
Palo Alto, California 94304

Stanford University
Palo Alto, California 94304

UC San Diego Moores Cancer center
San Diego, California 92037

University of California San Francisco Benioff Children's Hospital
San Francisco, California 94143

Children's Hospital Colorado
Aurora, Colorado 80045

Children's National Medical Center
Washington, District of Columbia 20010

University of Florida
Gainesville, Florida 32610

All Childrens Research Institute
Saint Petersburg, Florida 33606

All Children's Research Institute
Saint Petersburg, Florida 33701

Emory University-AFLAC Cancer and Blood Disorder Clinic
Atlanta, Georgia 30322

Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois 60611

University of Chicago
Chicago, Illinois 60637

Children's Mercy Hospital
Kansas City, Kansas 64108

University of Louisville-Kosair Childrens Hospital
Louisville, Kentucky 40292

Children's Hospital New Orleans
New Orleans, Louisiana 70118

Brigham & Woman's Hospital/Boston
Boston, Massachusetts 02115

Michigan State/Spectrum Health
Grand Rapids, Michigan 49503

Washington University
Saint Louis, Missouri 63130

University of Nebraska
Omaha, Nebraska 68198-5400

Hackensack University MC
Hackensack, New Jersey 07601

The Children's Hospital at Montefiore
Bronx, New York 10467

Weill Conrell Medical Center
New York, New York 10021

Morgan Stanley Children's Hospital
New York, New York 10032

Memorial Sloan Kettering
New York, New York 10065

New York Medical College-Maria Fareri Childrens hospital
New York, New York 10595

New York Medical College, Maria Fareri Children's Hospital
Valhalla, New York 10595

Levine Children's Hospital
Charlotte, North Carolina 28203

Duke University Medical System
Durham, North Carolina 27710

Cincinnatti Children's Hospital
Cincinnati, Ohio 45229

Cleveland Clinic
Cleveland, Ohio 44195

Nationwide Children's Hospital
Columbus, Ohio 43205

The Childrens hospital of Philadelphia
Philadelphia, Pennsylvania 19104

Methodist University Hospital-BMT program west clinic
Memphis, Tennessee 38104

St. Jude Research Hospital
Memphis, Tennessee 38105

UT Southwestern Medical Center
Dallas, Texas 75235

Cook Children's Health Care System
Fort Worth, Texas 76104

Baylor College of Medicine-Infectious Disease
Houston, Texas 77030

University of Texas, MD Anderson Cancer Center
Houston, Texas 77030

Methodist Children's Hospital of South Texas
San Antonio, Texas 78229

University of Washington/ Seattle Children's Hospital
Seattle, Washington 98105

Fred Hutchinson Cancer Research Center
Seattle, Washington 98195

Medical College of Wisconsin
Wauwatosa, Wisconsin 53226

More Details

NCT ID
NCT02596997
Status
No longer available
Sponsor
Chimerix

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.